{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:50:38Z","timestamp":1794639038112,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T00:00:00Z","timestamp":1575504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2014-54604-C3-1-R"],"award-info":[{"award-number":["SAF2014-54604-C3-1-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2014-54604-C3-2-R"],"award-info":[{"award-number":["SAF2014-54604-C3-2-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF2017-83151-R"],"award-info":[{"award-number":["SAF2017-83151-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","award":["CIVP18A3935"],"award-info":[{"award-number":["CIVP18A3935"]}],"id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["P01NS097197"],"award-info":[{"award-number":["P01NS097197"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["Prometeo2018\/135"],"award-info":[{"award-number":["Prometeo2018\/135"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s12035-019-01842-z","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T09:06:50Z","timestamp":1575536810000},"page":"1607-1621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Reactive Glia-Derived Neuroinflammation: a Novel Hallmark in Lafora Progressive Myoclonus Epilepsy That Progresses with Age"],"prefix":"10.1007","volume":"57","author":[{"given":"Marcos","family":"Lahuerta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daym\u00e9","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alihamze","family":"Fathinajafabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Garc\u00eda-Gim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Moreno-Estell\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rom\u00e1-Mateo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Knecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico V.","family":"Pallard\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2399-4103","authenticated-orcid":false,"given":"Pascual","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,5]]},"reference":[{"issue":"S2","key":"1842_CR1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1684\/epd.2016.0842","volume":"18","author":"J Turnbull","year":"2016","unstructured":"Turnbull J, Tiberia E, Striano P, Genton P, Carpenter S, Ackerley CA, Minassian BA (2016) Lafora disease. Epileptic Disord 18(S2):38\u201362","journal-title":"Epileptic Disord"},{"issue":"8","key":"1842_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/cells7080087","volume":"7","author":"Maria Garc\u00eda-Gimeno","year":"2018","unstructured":"Garcia-Gimeno MA, Knecht E, Sanz P (2018) Lafora disease: a ubiquitination-related pathology. Cells 7(8)","journal-title":"Cells"},{"issue":"2","key":"1842_CR3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/2470","volume":"20","author":"BA Minassian","year":"1998","unstructured":"Minassian BA, Lee JR, Herbrick JA, Huizenga J, Soder S, Mungall AJ, Dunham I, Gardner R et al (1998) Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet 20(2):171\u2013174","journal-title":"Nat Genet"},{"issue":"2","key":"1842_CR4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/8.2.345","volume":"8","author":"JM Serratosa","year":"1999","unstructured":"Serratosa JM, Gomez-Garre P, Gallardo ME, Anta B, de Bernabe DB, Lindhout D, Augustijn PB, Tassinari CA et al (1999) A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). Hum Mol Genet 8(2):345\u2013352","journal-title":"Hum Mol Genet"},{"issue":"2","key":"1842_CR5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/ng1238","volume":"35","author":"EM Chan","year":"2003","unstructured":"Chan EM, Young EJ, Ianzano L, Munteanu I, Zhao X, Christopoulos CC, Avanzini G, Elia M et al (2003) Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat Genet 35(2):125\u2013127","journal-title":"Nat Genet"},{"issue":"24","key":"1842_CR6","doi-asserted-by":"crossref","first-page":"8501","DOI":"10.1073\/pnas.0503285102","volume":"102","author":"MS Gentry","year":"2005","unstructured":"Gentry MS, Worby CA, Dixon JE (2005) Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc Natl Acad Sci U S A 102(24):8501\u20138506","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"1842_CR7","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1093\/hmg\/ddi306","volume":"14","author":"H Lohi","year":"2005","unstructured":"Lohi H, Ianzano L, Zhao XC, Chan EM, Turnbull J, Scherer SW, Ackerley CA, Minassian BA (2005) Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy. Hum Mol Genet 14(18):2727\u20132736","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1842_CR8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/hmg\/ddm339","volume":"17","author":"MC Solaz-Fuster","year":"2008","unstructured":"Solaz-Fuster MC, Gimeno-Alcaniz JV, Ros S, Fernandez-Sanchez ME, Garcia-Fojeda B, Criado Garcia O, Vilchez D, Dominguez J et al (2008) Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway. Hum Mol Genet 17(5):667\u2013678","journal-title":"Hum Mol Genet"},{"issue":"Pt A","key":"1842_CR9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.freeradbiomed.2015.01.034","volume":"88","author":"C Roma-Mateo","year":"2015","unstructured":"Roma-Mateo C, Aguado C, Garcia-Gimenez JL, Knecht E, Sanz P, Pallardo FV (2015) Oxidative stress, a new hallmark in the pathophysiology of Lafora progressive myoclonus epilepsy. Free Radic Biol Med 88(Pt A):30\u201341","journal-title":"Free Radic Biol Med"},{"key":"1842_CR10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1212\/01.WNL.0000154519.10805.F7","volume":"64","author":"C G\u00f3mez-Abad","year":"2005","unstructured":"G\u00f3mez-Abad C, G\u00f3mez-Garre P, Guti\u00e9rrez-Delicado E, Saygi S, Michelucci R, Tassinari CA, Rodriguez de Cordoba S, Serratosa JM (2005) Lafora disease due to EPM2B mutations. A clinical and genetic study. Neurology 64:982\u2013986","journal-title":"Neurology"},{"issue":"11","key":"1842_CR11","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/hmg\/11.11.1251","volume":"11","author":"S Ganesh","year":"2002","unstructured":"Ganesh S, Delgado-Escueta AV, Sakamoto T, Avila MR, Machado-Salas J, Hoshii Y, Akagi T, Gomi H et al (2002) Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum Mol Genet 11(11):1251\u20131262","journal-title":"Hum Mol Genet"},{"issue":"33","key":"1842_CR12","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M110.148668","volume":"285","author":"AA DePaoli-Roach","year":"2010","unstructured":"DePaoli-Roach AA, Tagliabracci VS, Segvich DM, Meyer CM, Irimia JM, Roach PJ (2010) Genetic depletion of the malin E3 ubiquitin ligase in mice leads to Lafora bodies and the accumulation of insoluble laforin. J Biol Chem 285(33):25372\u201325381","journal-title":"J Biol Chem"},{"issue":"11","key":"1842_CR13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/emmm.201100174","volume":"3","author":"J Valles-Ortega","year":"2011","unstructured":"Valles-Ortega J, Duran J, Garcia-Rocha M, Bosch C, Saez I, Pujadas L, Serafin A, Canas X et al (2011) Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease. EMBO Molecular Medicine 3(11):667\u2013681","journal-title":"EMBO Molecular Medicine"},{"issue":"7","key":"1842_CR14","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/hmg\/ddr590","volume":"21","author":"O Criado","year":"2012","unstructured":"Criado O, Aguado C, Gayarre J, Duran-Trio L, Garcia-Cabrero AM, Vernia S, San Millan B, Heredia M et al (2012) Lafora bodies and neurological defects in malin-deficient mice correlate with impaired autophagy. Hum Mol Genet 21(7):1521\u20131533","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1842_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/NEN.0b013e318253350f","volume":"71","author":"AM Garcia-Cabrero","year":"2012","unstructured":"Garcia-Cabrero AM, Marinas A, Guerrero R, de Cordoba SR, Serratosa JM, Sanchez MP (2012) Laforin and malin deletions in mice produce similar neurologic impairments. J Neuropathol Exp Neurol 71(5):413\u2013421","journal-title":"J Neuropathol Exp Neurol"},{"key":"1842_CR16","first-page":"291","volume":"8","author":"AM Garcia-Cabrero","year":"2014","unstructured":"Garcia-Cabrero AM, Sanchez-Elexpuru G, Serratosa JM, Sanchez MP (2014) Enhanced sensitivity of laforin- and malin-deficient mice to the convulsant agent pentylenetetrazole. Front Neurosci 8:291","journal-title":"Front Neurosci"},{"issue":"14","key":"1842_CR17","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1093\/hmg\/ddq190","volume":"19","author":"C Aguado","year":"2010","unstructured":"Aguado C, Sarkar S, Korolchuk VI, Criado O, Vernia S, Boya P, Sanz P, de Cordoba SR et al (2010) Laforin, the most common protein mutated in Lafora disease, regulates autophagy. Hum Mol Genet 19(14):2867\u20132876","journal-title":"Hum Mol Genet"},{"issue":"8","key":"1842_CR18","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.4161\/auto.6.8.13307","volume":"6","author":"R Puri","year":"2010","unstructured":"Puri R, Ganesh S (2010) Laforin in autophagy: a possible link between carbohydrate and protein in Lafora disease? Autophagy 6(8):1229\u20131231","journal-title":"Autophagy"},{"issue":"4","key":"1842_CR19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002037","volume":"7","author":"J Turnbull","year":"2011","unstructured":"Turnbull J, DePaoli-Roach AA, Zhao X, Cortez MA, Pencea N, Tiberia E, Piliguian M, Roach PJ et al (2011) PTG depletion removes Lafora bodies and rescues the fatal epilepsy of Lafora disease. PLoS Genet 7(4):e1002037","journal-title":"PLoS Genet"},{"issue":"5","key":"1842_CR20","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1007\/s12035-016-9884-4","volume":"54","author":"I Lopez-Gonzalez","year":"2017","unstructured":"Lopez-Gonzalez I, Viana R, Sanz P, Ferrer I (2017) Inflammation in Lafora disease: evolution with disease progression in laforin and malin knock-out mouse models. Mol Neurobiol 54(5):3119\u20133130","journal-title":"Mol Neurobiol"},{"issue":"24","key":"1842_CR21","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1093\/hmg\/ddx357","volume":"26","author":"A Rai","year":"2017","unstructured":"Rai A, Mishra R, Ganesh S (2017) Suppression of leptin signaling reduces polyglucosan inclusions and seizure susceptibility in a mouse model for Lafora disease. Hum Mol Genet 26(24):4778\u20134785","journal-title":"Hum Mol Genet"},{"issue":"3","key":"1842_CR22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017820","volume":"6","author":"D Bottomly","year":"2011","unstructured":"Bottomly D, Walter NA, Hunter JE, Darakjian P, Kawane S, Buck KJ, Searles RP, Mooney M et al (2011) Evaluating gene expression in C57BL\/6J and DBA\/2J mouse striatum using RNA-Seq and microarrays. PLoS One 6(3):e17820","journal-title":"PLoS One"},{"issue":"9","key":"1842_CR23","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nbt.3001","volume":"32","author":"C Wang","year":"2014","unstructured":"Wang C, Gong B, Bushel PR, Thierry-Mieg J, Thierry-Mieg D, Xu J, Fang H, Hong H et al (2014) The concordance between RNA-seq and microarray data depends on chemical treatment and transcript abundance. Nat Biotechnol 32(9):926\u2013932","journal-title":"Nat Biotechnol"},{"issue":"3","key":"1842_CR24","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","volume":"11","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, Oshlack A (2010) A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11(3):R25","journal-title":"Genome Biol"},{"issue":"21","key":"1842_CR25","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1093\/bioinformatics\/btm453","volume":"23","author":"MD Robinson","year":"2007","unstructured":"Robinson MD, Smyth GK (2007) Moderated statistical tests for assessing differences in tag abundance. Bioinformatics 23(21):2881\u20132887","journal-title":"Bioinformatics"},{"issue":"2","key":"1842_CR26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/biostatistics\/kxm030","volume":"9","author":"MD Robinson","year":"2008","unstructured":"Robinson MD, Smyth GK (2008) Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics 9(2):321\u2013332","journal-title":"Biostatistics"},{"key":"1842_CR27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-1-4939-3578-9_19","volume":"1418","author":"AT Lun","year":"2016","unstructured":"Lun AT, Chen Y, Smyth GK (2016) It\u2019s DE-licious: a recipe for differential expression analyses of RNA-seq experiments using quasi-likelihood methods in edgeR. Methods Mol Biol 1418:391\u2013416","journal-title":"Methods Mol Biol"},{"key":"1842_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini YaH","year":"1995","unstructured":"Benjamini YaH Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society Series B 57:289\u2013300","journal-title":"Journal of the Royal Statistical Society Series B"},{"issue":"10","key":"1842_CR29","doi-asserted-by":"crossref","first-page":"428","DOI":"10.6026\/97320630002428","volume":"2","author":"W da Huang","year":"2008","unstructured":"da Huang W, Sherman BT, Stephens R, Baseler MW, Lane HC, Lempicki RA (2008) DAVID gene ID conversion tool. Bioinformation 2(10):428\u2013430","journal-title":"Bioinformation"},{"issue":"15","key":"1842_CR30","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG (2012) Primer3\u2014new capabilities and interfaces. Nucleic Acids Res 40(15):e115","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1842_CR31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neulet.2005.07.002","volume":"387","author":"S Ganesh","year":"2005","unstructured":"Ganesh S, Tsurutani N, Amano K, Mittal S, Uchikawa C, Delgado-Escueta AV, Yamakawa K (2005) Transcriptional profiling of a mouse model for Lafora disease reveals dysregulation of genes involved in the expression and modification of proteins. Neurosci Lett 387(2):62\u201367","journal-title":"Neurosci Lett"},{"key":"1842_CR32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-015-0203-5","volume":"3","author":"IR Holtman","year":"2015","unstructured":"Holtman IR, Raj DD, Miller JA, Schaafsma W, Yin Z, Brouwer N, Wes PD, Moller T et al (2015) Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun 3:31","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"1842_CR33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/mp.2016.243","volume":"23","author":"SS Kang","year":"2018","unstructured":"Kang SS, Ren Y, Liu CC, Kurti A, Baker KE, Bu G, Asmann Y, Fryer JD (2018) Lipocalin-2 protects the brain during inflammatory conditions. Mol Psychiatry 23(2):344\u2013350","journal-title":"Mol Psychiatry"},{"key":"1842_CR34","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.1038\/ncomms11295","volume":"7","author":"K Srinivasan","year":"2016","unstructured":"Srinivasan K, Friedman BA, Larson JL, Lauffer BE, Goldstein LD, Appling LL, Borneo J, Poon C et al (2016) Untangling the brain\u2019s neuroinflammatory and neurodegenerative transcriptional responses. Nat Commun 7:11295","journal-title":"Nat Commun"},{"issue":"18","key":"1842_CR35","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, Barres BA (2012) Genomic analysis of reactive astrogliosis. J Neurosci 32(18):6391\u20136410","journal-title":"J Neurosci"},{"issue":"36","key":"1842_CR36","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O'Keeffe S, Phatnani HP, Guarnieri P et al (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci 34(36):11929\u201311947","journal-title":"J Neurosci"},{"issue":"1","key":"1842_CR37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13041-018-0376-5","volume":"11","author":"DB Bosco","year":"2018","unstructured":"Bosco DB, Zheng J, Xu Z, Peng J, Eyo UB, Tang K, Yan C, Huang J et al (2018) RNAseq analysis of hippocampal microglia after kainic acid-induced seizures. Mol Brain 11(1):34","journal-title":"Mol Brain"},{"issue":"8","key":"1842_CR38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","volume":"15","author":"A Vezzani","year":"2019","unstructured":"Vezzani A, Balosso S, Ravizza T (2019) Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol 15(8):459\u2013472","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"1842_CR39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/NEN.0b013e31823e68e1","volume":"71","author":"S Tegelberg","year":"2012","unstructured":"Tegelberg S, Kopra O, Joensuu T, Cooper JD, Lehesjoki AE (2012) Early microglial activation precedes neuronal loss in the brain of the Cstb\u2212\/\u2212 mouse model of progressive myoclonus epilepsy, EPM1. J Neuropathol Exp Neurol 71(1):40\u201353","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"1842_CR40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089321","volume":"9","author":"T Joensuu","year":"2014","unstructured":"Joensuu T, Tegelberg S, Reinmaa E, Segerstrale M, Hakala P, Pehkonen H, Korpi ER, Tyynela J et al (2014) Gene expression alterations in the cerebellum and granule neurons of Cstb(\u2212\/\u2212) mouse are associated with early synaptic changes and inflammation. PLoS One 9(2):e89321","journal-title":"PLoS One"},{"issue":"3","key":"1842_CR41","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/glia.22760","volume":"63","author":"O Okuneva","year":"2015","unstructured":"Okuneva O, Korber I, Li Z, Tian L, Joensuu T, Kopra O, Lehesjoki AE (2015) Abnormal microglial activation in the Cstb(\u2212\/\u2212) mouse, a model for progressive myoclonus epilepsy, EPM1. Glia 63(3):400\u2013411","journal-title":"Glia"},{"issue":"1","key":"1842_CR42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-016-0764-7","volume":"13","author":"O Okuneva","year":"2016","unstructured":"Okuneva O, Li Z, Korber I, Tegelberg S, Joensuu T, Tian L, Lehesjoki AE (2016) Brain inflammation is accompanied by peripheral inflammation in Cstb (\u2212\/\u2212) mice, a model for progressive myoclonus epilepsy. J Neuroinflammation 13(1):298","journal-title":"J Neuroinflammation"},{"issue":"7","key":"1842_CR43","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/hmg\/ddy044","volume":"27","author":"C Rubio-Villena","year":"2018","unstructured":"Rubio-Villena C, Viana R, Bonet J, Garcia-Gimeno MA, Casado M, Heredia M, Sanz P (2018) Astrocytes: new players in progressive myoclonus epilepsy of Lafora type. Hum Mol Genet 27(7):1290\u20131300","journal-title":"Hum Mol Genet"},{"issue":"8","key":"1842_CR44","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1080\/21645515.2015.1034921","volume":"11","author":"N Matin","year":"2015","unstructured":"Matin N, Tabatabaie O, Falsaperla R, Lubrano R, Pavone P, Mahmood F, Gullotta M, Serra A et al (2015) Epilepsy and innate immune system: a possible immunogenic predisposition and related therapeutic implications. Hum Vaccin Immunother 11(8):2021\u20132029","journal-title":"Hum Vaccin Immunother"},{"issue":"Suppl 3","key":"1842_CR45","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/epi.13783","volume":"58","author":"E Aronica","year":"2017","unstructured":"Aronica E, Bauer S, Bozzi Y, Caleo M, Dingledine R, Gorter JA, Henshall DC, Kaufer D et al (2017) Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia 58(Suppl 3):27\u201338","journal-title":"Epilepsia"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01842-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-019-01842-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-019-01842-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T05:24:19Z","timestamp":1722144259000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-019-01842-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,5]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["1842"],"URL":"https:\/\/doi.org\/10.1007\/s12035-019-01842-z","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,5]]},"assertion":[{"value":"6 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Consejo Superior de Investigaciones Cientificas (CSIC, Spain) and approved by the Conseller\u00eda de Agricultura, Medio Ambiente, Cambio Clim\u00e1tico y Desarrollo Rural from the <i>Generalitat Valenciana<\/i>. All mouse procedures were approved by the animal committee of the Instituto de Biomedicina de Valencia-CSIC [Permit Number: (IBV-16), 2015\/VSC\/PEA\/00029].","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}